Numerous groups have studied the role of TLR4/MAPK signaling in cardiac hypertrophy using pharmacological inhibitors or genetic knockout mice, that directly or indirectly regulate ERK1/2, JNK, and p38 MAPK. Here, TLR4 is linked to cardiac hypertrophy.